# An unknown cannabinoid receptor helps alleviate secondary brain damages through regulating microglial cells and astrocytes of the brain. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/unknown-cannabinoid-receptor-brain-damage-relief/ > **Published:** 2021-01-12T14:16:27-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:17:17-04:00 > **Clinical Summary:** Explore how the unknown cannabinoid receptor brain damage relief regulates microglial cells and astrocytes to reduce secondary brain damage inflammation. --- ### Abnormal Cannabidiol Affects Production of Pro‐Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic‐Microglial Cocultures ​In Summary Damage to the brain such as brain trauma or stroke comprises two consecutive events. The initial one, primary damage, involves loss of neurons. It is then followed by a secondary damage, which is characterized by complex inflammatory cascades that aggravate the initial loss. The [inflammatory response](https://cedclinic.com/synthetic-cannabinoid-win55212-2-mesylate-rheumatoid-arthritis/) is regulated by two types of supporting cells in the brain, microglia and astrocytes. More specifically, while a rapid production and hence increase in the number of astrocytes at the site of damage represents a form of scar forming and wound healing, the simultaneous accumulation of both microglia and astrocytes lead to excessive inflammatory reactions that are associated with secondary damage. ​ Endocannabinoid is a group of lipids naturally produced by the body, and shares similar structures and functions with cannabinoids derived from plants such as cannabis or synthesized artificially. Compounds in this group exert their effects on the body by binding to and activating [cannabinoid receptors](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/) on the cells. Recently, scientists discovered a previously unknown cannabinoid receptor that is widely expressed on both microglial cells and astrocytes and regulates their migration and functions. Excitingly, activation of this new receptor was shown to increase blood flow and therefore alleviate damages caused by stroke to the brain in lab rats. Although the mechanism underlying this effect is complicated and needs further research to fully elucidate, scientists suggested this receptor, when activated, reduces accumulation of and attenuate the [inflammatory response](https://cedclinic.com/synthetic-cannabinoid-win55212-2-mesylate-rheumatoid-arthritis/) by microglial cells. It also mediates the reorganization and wound closure reaction of astrocytes. [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Neurological and neurodegenerative conditions, physical activities, and the endocannabinoid system – how might all these be linked?](https://cedclinic.com/endocannabinoid-system-neurological-disorders-link/) Explore the connections between neurological conditions, physical activity, and the endocannabinoid system's role in [brain health](https://cedclinic.com/cognitive-flexibility-alcohol-cocaine-misuse-effects/). [Read More](https://cedclinic.com/endocannabinoid-system-neurological-disorders-link/) [Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics](https://cedclinic.com/cannabinoid-receptor-type-2-anti-inflammatory-effects-se/) Learn about cannabinoid receptor type 2's neuroprotective and [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) in brain injury models. [Discover More](https://cedclinic.com/cannabinoid-receptor-type-2-anti-inflammatory-effects-se/) [The endocannabinoid receptor CB2 is a regulator of trauma-inducing anxiety and a potential target for PTSD drugs](https://cedclinic.com/cannabinoid-cb2-receptors-anxiety-ptsd-regulation/) Understand how the [CB2 receptor](https://cedclinic.com/s-caryophyllene-a-terpine-found-in-cannabis-demonstrates-therapeutic-potential-in-a-mouse-model-of-ms/) modulates trauma-related anxiety and its therapeutic potential in PTSD. [Learn More](https://cedclinic.com/cannabinoid-cb2-receptors-anxiety-ptsd-regulation/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=An%20unknown%20cannabinoid%20receptor%20helps%20alleviate%20secondary%20brain%20damages%20through%20regulating%20microglial%20cells%20and%20astrocytes%20of%20the%20brain.&url=https%3A%2F%2Fcedclinic.com%2Funknown-cannabinoid-receptor-brain-damage-relief%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Funknown-cannabinoid-receptor-brain-damage-relief%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=An%20unknown%20cannabinoid%20receptor%20helps%20alleviate%20secondary%20brain%20damages%20through%20regulating%20microglial%20cells%20and%20astrocytes%20of%20the%20brain.%20https%3A%2F%2Fcedclinic.com%2Funknown-cannabinoid-receptor-brain-damage-relief%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).